Privacy settings

We use technical cookies, that are necessary for the management of the website, statistical cookies and marketing cookies (including third parties cookies) for displaying individual offers and ads. For more information read our Privacy Policy. Statistical cookies and marketing cookies (inclusive of third parties cookies) are used only with your consent. By clicking “Select all and agree” you consent to our use of statistical and/or marketing cookies (inclusive of third parties cookies).

To customize your privacy settings, tick your preferences in the checkboxes and click “Apply selection”. You can always change the privacy settings and deactivate cookies by following the instructions in the Privacy Policy.

Show preferences Select all and accept
IMA is loading

Main Financial Data 2003

Main Data: 31/12 Year 2003
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 351.33
– gross margin 149.54
– total operating cost 105.21
– net operating profit 39.25
– financial expenses, netv 4.01
– net income before taxes 18.96

 

Consolidated balance sheet Millions/Euro
– operating capital 78.20
– fixed assets, net 102.14
– reserves and MLT non financial payables – 13.74
– net financial position – 68.49
– stockholders’ equity 98.11

 

Other Information Millions/Euro
– depreciation 15.65
– R & D expenses 18.21

 

  Euro
Dividend per share 0.40

 

  No.
Employees 2,400

 

  Euro
Shares outstanding 18,772,000

 

Main Data: 30/06 Year 2003
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 143.72
– gross margin 57.82
– total operating cost 54.03
– net operating profit 1.24
– financial expenses, net 0.18
– net income before taxes 0.45

 

Consolidated balance sheet Millions/Euro
– operating capital 92.46
– fixed assets, net 103.05
– reserves and MLT non financial payables – 14.91
– net financial position 85.77
– stockholders’ equity 94.83

 

Other information Millions/Euro
– depreciation 7.58
– R & D expenses 9.60

 

  No.
Employees 2,382

 

  Euro
Shares outstanding 18,772,000

 

Net Sales by Sector: Year 2003
  Millions/Euro  
tea, herbs & coffee 56.96 16.21%
pharmaceuticals packaging 208.52 59.35%
pharmaceuticals processing 85.85 24.44%
Total 351.33 100.00%

 

Net Sales by Country: Year 2003
  Millions/Euro  
E.U. (excluding Italy) 146.56 41.72%
Other European countries 37.37 10.64%
North America 71.86 20.45%
Asia & Middle East 37.36 10.63%
Other countries 28.92 8.23%
Total exports 322.07 91.67%
Italy 29.26 8.33%
Total 351.33 100.00%